Publicado 6 números por año
ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502
Indexed in
Approaches for Skeletal Gene Therapy
SINOPSIS
The role of gene therapy in the treatment of musculoskeletal disorders continues to be an active area of research. As the etiology of many musculoskeletal diseases becomes increasingly understood, advances in cellular and gene therapy may be applied to their potential treatment. This review focuses on current investigational strategies to treat osteogenesis imperfecta (OI). OI is a varied group of genetic disorders that result in the diminished integrity of connective tissues as a result of alterations in the genes that encode for either the proal or proa2 component of type I collagen. Because most forms of OI result from dominant negative mutations, isolated gene replacement therapy is not a logical treatment option. The combined use of genetic manipulation and cellular transplantation, however, may provide a means to overcome this obstacle. This article describes the recent laboratory and clinical advances in cell therapy, highlights potential techniques being investigated to suppress the expression of the mutant allele with antisense gene therapy, and attempts to deliver collagen genes to bone cells. The challenges that the investigators face in their quest for the skeletal gene therapy are also discussed.
-
Devogelaer Jean-Pierre, Coppin Christine, Osteogenesis Imperfecta, Treatments in Endocrinology, 5, 4, 2006. Crossref
-
Jullig Mia, Zhang Wei V., Stott N. Susan, Gene therapy in orthopaedic surgery: the current status, ANZ Journal of Surgery, 74, 1-2, 2004. Crossref
-
Cabral Wayne A., Marini Joan C., High Proportion of Mutant Osteoblasts Is Compatible with Normal Skeletal Function in Mosaic Carriers of Osteogenesis Imperfecta**Presented as a platform presentation at the National Meeting of the American Society of Bone and Mineral Research (Late-Breaking Research Session), San Antonio, TX, September 2002., The American Journal of Human Genetics, 74, 4, 2004. Crossref
-
Niyibizi Christopher, Wang Sujing, Mi Zhibao, Robbins Paul D, The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells, Molecular Therapy, 9, 6, 2004. Crossref
-
Kamb Alexander, Ramaswami Mani, Rao Mahendra S., Therapeutic Uses of Embryonic Stem Cells, in Human Embryonic Stem Cells, 2003. Crossref
-
Wang Liping, Liu Yaling, Kalajzic Zana, Jiang Xi, Rowe David W., Heterogeneity of engrafted bone-lining cells after systemic and local transplantation, Blood, 106, 10, 2005. Crossref